SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Acacia Research Corp. – ‘8-K’ for 7/28/20

On:  Monday, 8/3/20, at 4:30pm ET   ·   For:  7/28/20   ·   Accession #:  1683168-20-2473   ·   File #:  1-37721

Previous ‘8-K’:  ‘8-K’ on / for 7/20/20   ·   Next:  ‘8-K’ on / for 8/10/20   ·   Latest:  ‘8-K’ on / for 4/17/24   ·   3 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/03/20  Acacia Research Corp.             8-K:5,9     7/28/20    2:27K                                    GlobalOne Filings Inc/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     14K 
 2: EX-3.1      Certificate of Amendment of the Second Amended and  HTML      7K 
                Restated Bylaws of Acacia Research Corporation A                 
                Delaware Corporation                                             


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 28, 2020

 

ACACIA RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)

 

 

Delaware 001-37721 95-4405754
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

 

4 Park Plaza, Suite 550

Irvine, California

92614
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code:          (949) 480-8300

 

Not applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   ACTG   The NASDAQ Stock Market, LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 C: 
   

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On July 28, 2020, the Board of Directors (the “Board”) of Acacia Research Corporation (the “Company”) adopted a Certificate of Amendment (the Bylaw Amendment”) of the Second Amended and Restated Bylaws of the Company (the Bylaws) to provide that (i) unless the Company consents in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for the resolution of any claims under the Securities Act of 1933, as amended, and (ii) consistent with the Company’s Amended and Restated Certificate of Incorporation, the Bylaws may be amended or repealed either by approval of 66 2/3% of the outstanding shares of the Company entitled to vote on such action or by the approval of the Board, for those amendments to the Bylaws for which Board approval alone is sufficient under the General Corporation Law of Delaware .

 

The foregoing description of the Bylaw Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Bylaw Amendment, a copy of which is attached as Exhibit 3.1 to this Current Report and is incorporated herein by reference.

 

Item 9.01. Financial Statements and Exhibits.

 

(d)     Exhibits

 

Exhibit No.   Description of Exhibit
3.1   Certificate of Amendment of the Second Amended and Restated Bylaws of Acacia Research Corporation

 

 

 

 

 C: 
  C: 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ACACIA RESEARCH CORPORATION
   
   
Date: August 3, 2020 /s/ Clifford Press  
  Chief Executive Officer

 

 

 

 

 

 

 

 

 C: 
  C: 3 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:8/3/20None on these Dates
For Period end:7/28/20
 List all Filings 


3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/25/20  Acacia Research Corp.             424B5                  1:349K                                   GlobalOne Filings Inc/FA
11/19/20  Acacia Research Corp.             S-3/A      11/18/20    2:309K                                   GlobalOne Filings Inc/FA
11/09/20  Acacia Research Corp.             S-3                    4:703K                                   GlobalOne Filings Inc/FA
Top
Filing Submission 0001683168-20-002473   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 9:25:56.2am ET